Literature DB >> 17546041

Assessment of MLH1 promoter methylation in relation to gene expression requires specific analysis.

E Capel1, J-F Fléjou, R Hamelin.   

Abstract

About 15% of colorectal cancers are called MSI because they demonstrate microsatellite instability. In most sporadic MSI cases, the DNA mismatch repair (MMR) defect is due to methylation of the MLH1 promoter. In hereditary MSI cases, it is the consequence of germline mutations of one of the MMR genes. We analysed the MLH1 promoter for methylation using the methylation-specific PCR technique. With a previously described and widely used primer set, a number of samples with an intact MMR system were found to have methylated MLH1 promoter, a finding normally associated with lack of MLH1 expression. Another primer set, specific for a more proximal region of the promoter, gave results that correlated more closely with loss of MLH1 expression. We then conducted a survey of the literature on the subject, and a total of 161 articles were examined. Although it was shown as early as 1999 that absence of MLH1 expression correlated with methylation of the proximal but not distal regions of the MLH1 promoter, 60% of published studies analysed nonspecific regions. Our findings suggest that these studies are likely to have wrongly estimated the association between methylation of the MLH1 gene and the lack of its protein expression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17546041     DOI: 10.1038/sj.onc.1210581

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  20 in total

1.  Regulation of MLH1 mRNA and protein expression by promoter methylation in primary colorectal cancer: a descriptive and prognostic cancer marker study.

Authors:  Lars Henrik Jensen; Anders Aamann Rasmussen; Lene Byriel; Hidekazu Kuramochi; Dorthe Gylling Crüger; Jan Lindebjerg; Peter V Danenberg; Anders Jakobsen; Kathleen Danenberg
Journal:  Cell Oncol (Dordr)       Date:  2013-09-12       Impact factor: 6.730

2.  Male germline transmits fetal alcohol adverse effect on hypothalamic proopiomelanocortin gene across generations.

Authors:  Dmitry Govorko; Rola A Bekdash; Changqing Zhang; Dipak K Sarkar
Journal:  Biol Psychiatry       Date:  2012-05-22       Impact factor: 13.382

3.  Germline promoter hypermethylation of tumor suppressor genes in gastric cancer.

Authors:  Pu-Yuan Wu; Zheng Zhang; Jing-Mei Wang; Wen-Wen Guo; Nong Xiao; Qiong He; Ya-Ping Wang; Yi-Mei Fan
Journal:  World J Gastroenterol       Date:  2012-01-07       Impact factor: 5.742

4.  [DNA methylation. From basic research to routine diagnostics].

Authors:  U Lehmann
Journal:  Pathologe       Date:  2010-10       Impact factor: 1.011

5.  Methylation-mediated downregulation of the B-cell translocation gene 3 (BTG3) in breast cancer cells.

Authors:  Jingwei Yu; Yingsha Zhang; Zhongxia Qi; Daniel Kurtycz; Guido Vacano; David Patterson
Journal:  Gene Expr       Date:  2008

6.  Prenatal Ethanol Exposure and Neocortical Development: A Transgenerational Model of FASD.

Authors:  Charles W Abbott; David J Rohac; Riley T Bottom; Sahil Patadia; Kelly J Huffman
Journal:  Cereb Cortex       Date:  2018-08-01       Impact factor: 5.357

7.  Molecular subtype switching in early-stage gastric cancers with multiple occurrences.

Authors:  Shinya Takaoka; Yosuke Hirotsu; Hiroshi Ohyama; Hitoshi Mochizuki; Kenji Amemiya; Toshio Oyama; Hiroshi Ashizawa; Dai Yoshimura; Keiko Nakagomi; Kenji Hosoda; Yoji Suzuki; Yuichiro Kojima; Masao Omata
Journal:  J Gastroenterol       Date:  2019-01-21       Impact factor: 7.527

8.  Distinct BRAF (V600E) and KRAS mutations in high microsatellite instability sporadic colorectal cancer in African Americans.

Authors:  Krishan Kumar; Hassan Brim; Francis Giardiello; Duane T Smoot; Mehdi Nouraie; Edward L Lee; Hassan Ashktorab
Journal:  Clin Cancer Res       Date:  2009-02-03       Impact factor: 12.531

9.  Implementing screening for Lynch syndrome among patients with newly diagnosed colorectal cancer: summary of a public health/clinical collaborative meeting.

Authors:  Cecelia A Bellcross; Sara R Bedrosian; Elvan Daniels; Debra Duquette; Heather Hampel; Kory Jasperson; Djenaba A Joseph; Celia Kaye; Ira Lubin; Laurence J Meyer; Michele Reyes; Maren T Scheuner; Sheri D Schully; Leigha Senter; Sherri L Stewart; Jeanette St Pierre; Judith Westman; Paul Wise; Vincent W Yang; Muin J Khoury
Journal:  Genet Med       Date:  2011-10-27       Impact factor: 8.822

10.  Clinicopathological significance of deficient DNA mismatch repair and MLH1 promoter methylation in endometrioid endometrial carcinoma.

Authors:  Annukka Pasanen; Mikko Loukovaara; Ralf Bützow
Journal:  Mod Pathol       Date:  2020-02-14       Impact factor: 7.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.